Article Correctness Is Author's Responsibility: FDA Fast-Tracks Non-Opioid Treatment for Neuropathic Pain

The article below may contain offensive and/or incorrect content.

The treatment is currently being evaluated in a Phase 2 study (ELEVATE) in patients with major depressive disorder who have had an inadequate response to standard antidepressant therapy.